Printer Friendly

Vitamin C and tuberculosis; a neglected chapter in anti-bacterial research.

Twenty years ago, Irwin Stone unfolded his startling conclusions that vitamin C could be effective in preventing bacterial infection, in particular tuberculosis. He also presented evidence that documented its success in treating tuberculosis.

Despite impressive references, from 35 medical sources around the world, Dr. Stone's book, Vitamin C Against Disease, has been ignored in the medical literature.

Dr. Stone notes that not long after the discovery of vitamin C, enthusiasm for its use in dealing with bacterial infections was at a high level. The early workers in science laboratories had high hopes for acceptance of their discoveries.

He refers to the extensive work by investigators in large institutions and private laboratories that revealed vitamin C was an effective bactericide, an effective destroyer of most forms of tubercle bacilli. Other bacteria included Staphylococcus aureus (the pus organism), B.typhosus (the germ causing typhoid fever, B.coli (the organism from sewage), ad B.subtillis (a nonpathogenic bacterium).

Stone discovered that as little as 7,000 milligrams a day could raise the bactericidal (bacteria-killing potential) in the blood stream.

"Certain bacteria, during their growth elaborate and secrete deadly poisons or toxins," Stone says. "It has been found that ascorbic acid (vitamin C) has the power to neutralize, inactivate and render harmless a wide variety of these bacterial toxins."

Another of the body's defenses against invading pathogenic bacteria is the mobilization fo white blood cells in the site of infection, Dr. Stone explains. These white blood cells actually attack the bacteria, and engulf, digest and destroy the germs.

Because white blood cells ar edependent upon the plentiful presence of vitamin C in the blood and tissues, the integrity of the immune system is related to its pool of ascorbic acid, Stone declares.

Irwin Stone cites research evidence that links scurvy with tuberculosis (a high incidence of the deficiency disease with cases of tuberculosis).

"Many papers appeared which showed the increased need for ascorbic acid under the heavy biochemical stresses of tuberculosis infection," the author notes. He also refers to a five-year follow-up study conducted in the United States, Denmark, and other countries where cases of tuberculosis developed in men whose vitamin C levels were substandard.

Before his death, twenty years after his studies with vitamin C were published, Dr. Stone insisted that the correct use of vitamin C could eventually relegate tuberculosis to oblivion. In recent years, while antibiotics are meeting with only moderate success and long lists of side effects, Irwin Stone's proven theories and documented successes remain mysteriouly ignored.
COPYRIGHT 1991 Vegetus Publications
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Special Issue: Tuberculosis
Publication:Nutrition Health Review
Date:Jun 22, 1991
Words:417
Previous Article:A pictorial journey through humanity's battle against the white plague.
Next Article:A reminder from the past; only vigilance, a doctor warns, can keep the dreaded disease from flaring up again.
Topics:


Related Articles
Study sheds light on TB resistance.
Buffers against tuberculosis: vitamin D and zinc.
Seldom-reported research around the world: documenting important discoveries in vitamin c therapy.
Know Your Enemy.
Hospital Control and Multidrug-Resistant Pulmonary Tuberculosis in Female Patients, Lima, Peru.
The continued threat of tuberculosis. (Tubercolosis Genotyping Network).
A prospective, multicenter study of laboratory cross-contamination of mycobacterium tuberculosis cultures. (Tuberculosis Genotyping Network).
Boosting the TB vaccine. (Immunology).
Mycobacterium tuberculosis complex drug resistance in Italy.
Mycobacterium bovis isolates with M. tuberculosis specific characteristics.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters